Psychedelic Drugs Market Size, Share, Industry, Forecast and outlook (2024-2031)

Published: 2024 February 22
SKU : PH4673
excelpdfpowerpoint
180 pages
Report Summary
Table of Contents
List of Tables & Figures
loading
Buy this report
Single User
$4350
Multiple User
$4850
Enterprise User
$7850
Proceed to Buy
Request new version
FAQ’s
What is the Projected CAGR value of the Psychedelic Drugs Market?
Psychedelic Drugs Market is expected to grow at a CAGR of 12.6% during the forecasting period 2023-2030.
Which region controlled the global market during 2023-2030?
North America region Controls the Psychedelic Drugs Market during 2023-2030.
Which is the fastest growing region in the Psychedelic Drugs Market?
Asia Pacific is the fastest growing market share during the forecast period.
Who are the key players in Psychedelic Drugs Market?
Key players are Compass Pathways, MindMed, Hikma Pharmaceuticals, Celon Pharmaceuticals, Cybin Corp, Pfizer Inc., Jazz Pharmaceuticals Inc., Atai Life Sciences N.V., PharmaTher Holdings Ltd, and GH Research PLC.
Related Reports
pharmaceuticals

Psychotherapeutic Drugs Market Size, Share, Industry, Forecast and outlook (2024-2031)

Published: 2024 January 22
Starting from

$4350

pharmaceuticals

Post-Traumatic Stress Disorder Therapeutics Market Size, Share, Industry, Forecast and outlook (2024-2031)

Published: 2024 January 11
Starting from

$4350

pharmaceuticals

Narcolepsy Therapeutics Market Size, Share, Industry, Forecast and outlook (2024-2031)

Published: 2024 January 17
Starting from

$4350

pharmaceuticals

Opioids Drug Market Size, Share, Industry, Forecast and outlook (2024-2031)

Published: 2024 January 23
Starting from

$4350

pharmaceuticals

Antiemetic Drugs Market Size, Share, Industry, Forecast and outlook (2024-2031)

Published: 2024 January 22
Starting from

$4350

pharmaceuticals

Oral Thin Films Market Size, Share, Industry, Forecast and outlook (2024-2031)

Published: 2024 February 22
Starting from

$4350